Xu Hui Grace, Corley Amanda, Young Emily R, Doubrovsky Anna, Ware Robert S, Afoakwah Clifford, Wang Carrie, Stirling Scott, Marsh Nicole
School of Nursing, Queensland University of Technology, Brisbane, Queensland, Australia.
Department of Emergency Medicine, Queen Elizabeth II Jubilee Hospital, Brisbane, Queensland, Australia.
Acad Emerg Med. 2024 Dec;31(12):1223-1232. doi: 10.1111/acem.15004. Epub 2024 Sep 9.
A quarter of patients who present to emergency departments (EDs) have difficult intravenous access (DIVA), making it challenging for clinicians to successfully place a peripheral intravenous catheter (PIVC). Some literature suggests that guidewire PIVC improves first-insertion success rate.
The aim was to determine the clinical and cost-effectiveness of a novel long PIVC (5.8 cm) with a retractable coiled guidewire (GW-PIVC) for patients with DIVA, compared with standard care PIVCs.
A pragmatic randomized controlled trial was conducted in two Australian EDs. Eligible participants were adults assessed as meeting DIVA criteria. Participants were randomized (1:1 ratio; stratified by hospital) to either GW-PIVC (long) or standard care group (short or long PIVC). The use of ultrasound was discretionary in the standard care group and was recommended in the GW-PIVC group due to the pragmatic design that was primarily testing the GW-PIVC rather than the ultrasound use. Primary outcome was first-insertion success and secondary outcomes included all-cause device failure, patient and staff satisfaction, and cost-effectiveness. The analysis was intention to treat.
A total of 446 participants were randomized and 409 received PIVCs. The use of GW-PIVC, compared with standard PIVC, had a lower first-insertion success rate (68% vs. 77%, odds ratio [OR] 0.65, 95% confidence interval [CI] 0.43-0.99, p < 0.05). There was no difference in PIVC failure (134.0 per 1000 catheter days [GW-PIVC] vs. 111.8 [standard PIVC] per 1000 catheter days, hazard ratio 1.18, 95% CI 0.72-1.95). Both participant (8/10 vs. 9/10, median difference [MD] -1.00, 95% CI -1.37 to -0.63) and clinician (8/10 vs. 10/10, MD -2.00, 95% CI -2.37 to -1.63) satisfaction was lower with GW-PIVCs compared with standard PIVCs. More nurses inserted standard PIVCs than GW-PIVCs (56.9% vs. 36.5%) and had less confidence in their ultrasound skills (28.0% vs. 46.6% self-claimed as advanced/expert users). The cost per participant of GW-PIVC insertions was 2.46 times greater than standard PIVC insertions ($AU80.24 vs. $AU32.57).
GW-PIVCs had significantly lower first-insertion success and non-significantly higher all-cause catheter failure. Additional training and device design familiar to clinicians are vital factors to enhance the likelihood of successful future implementation of GW-PIVCs.
到急诊科就诊的患者中有四分之一存在静脉穿刺困难(DIVA),这使得临床医生成功置入外周静脉导管(PIVC)具有挑战性。一些文献表明,导丝引导下的PIVC可提高首次穿刺成功率。
旨在确定一种新型长外周静脉导管(5.8厘米)及可回缩螺旋导丝(GW-PIVC)与标准护理PIVC相比,用于DIVA患者的临床效果和成本效益。
在澳大利亚的两家急诊科进行了一项实用随机对照试验。符合条件的参与者为被评估符合DIVA标准的成年人。参与者按1:1比例随机分组(按医院分层),分为GW-PIVC组(长导管)或标准护理组(短或长PIVC)。在标准护理组中,超声的使用是酌情决定的,而在GW-PIVC组中,由于该实用设计主要是测试GW-PIVC而非超声的使用,因此建议使用超声。主要结局是首次穿刺成功,次要结局包括全因性置管失败、患者和医护人员满意度以及成本效益。分析采用意向性分析。
共有446名参与者被随机分组,409人接受了PIVC置管。与标准PIVC相比,GW-PIVC的首次穿刺成功率较低(68%对77%,优势比[OR]0.65,95%置信区间[CI]0.43 - 0.99,p<0.05)。PIVC失败情况无差异(GW-PIVC每1000导管日134.0次对标准PIVC每1000导管日111.8次,风险比1.18,95%CI 0.72 - 1.95)。与标准PIVC相比,GW-PIVC组患者(8/10对9/10,中位数差异[MD]-1.00,95%CI -1.37至-0.63)和临床医生(8/10对10/10,MD -2.00,95%CI -2.37至-1.63)的满意度较低。插入标准PIVC的护士比插入GW-PIVC的护士更多(56.9%对36.5%),且对其超声技能的信心较低(28.0%自称为高级/专家使用者对46.6%)。GW-PIVC置管每位参与者的成本比标准PIVC置管高2.46倍(80.24澳元对32.57澳元)。
GW-PIVC的首次穿刺成功率显著较低,全因性导管失败率虽无显著升高但也较高。对临床医生进行额外培训以及提供他们熟悉的设备设计是未来提高GW-PIVC成功应用可能性的关键因素。